Cancer BiologyEMBO ReportsPeer-reviewed
STAT3 Sustains Tumorigenicity Following Mutant KRAS Ablation
Stephen D’Amico, Varvara Kirillov, Jingxuan Liu…·Nancy C. Reich
This study shows that STAT3 sustains tumorigenicity in KRAS-ablated pancreatic cancer cells, highlighting its role in maintaining malignant identity and suggesting it as a therapeutic target.
2 citations